These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 18800881)
21. Challenges in the development of magnetic particles for therapeutic applications. Barry SE Int J Hyperthermia; 2008 Sep; 24(6):451-66. PubMed ID: 18608583 [TBL] [Abstract][Full Text] [Related]
22. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging. Zhang C; Wängler B; Morgenstern B; Zentgraf H; Eisenhut M; Untenecker H; Krüger R; Huss R; Seliger C; Semmler W; Kiessling F Langmuir; 2007 Jan; 23(3):1427-34. PubMed ID: 17241069 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs. Nadithe V; Rahamatalla M; Finlay WH; Mercer JR; Samuel J J Pharm Sci; 2003 May; 92(5):1066-76. PubMed ID: 12712427 [TBL] [Abstract][Full Text] [Related]
24. Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging. Cho WS; Cho M; Kim SR; Choi M; Lee JY; Han BS; Park SN; Yu MK; Jon S; Jeong J Toxicol Appl Pharmacol; 2009 Aug; 239(1):106-15. PubMed ID: 19520096 [TBL] [Abstract][Full Text] [Related]
25. Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer. Tseng CL; Wu SY; Wang WH; Peng CL; Lin FH; Lin CC; Young TH; Shieh MJ Biomaterials; 2008 Jul; 29(20):3014-22. PubMed ID: 18436301 [TBL] [Abstract][Full Text] [Related]
26. Guiding aerosol deposition in the lung. Coates AL N Engl J Med; 2008 Jan; 358(3):304-5. PubMed ID: 18199871 [No Abstract] [Full Text] [Related]
27. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Yang F; Li Y; Chen Z; Zhang Y; Wu J; Gu N Biomaterials; 2009 Aug; 30(23-24):3882-90. PubMed ID: 19395082 [TBL] [Abstract][Full Text] [Related]
28. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Stoll G; Bendszus M Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996 [TBL] [Abstract][Full Text] [Related]
29. Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Zhu MT; Feng WY; Wang Y; Wang B; Wang M; Ouyang H; Zhao YL; Chai ZF Toxicol Sci; 2009 Feb; 107(2):342-51. PubMed ID: 19023088 [TBL] [Abstract][Full Text] [Related]
30. Generation and characterization of respirable metallic oxide aerosols for pulmonary clearance studies in calves. Lay JC; Slauson DO Cornell Vet; 1987 Oct; 77(4):310-27. PubMed ID: 3446444 [TBL] [Abstract][Full Text] [Related]
31. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines. Martin AL; Bernas LM; Rutt BK; Foster PJ; Gillies ER Bioconjug Chem; 2008 Dec; 19(12):2375-84. PubMed ID: 19053308 [TBL] [Abstract][Full Text] [Related]
32. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging. Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158 [TBL] [Abstract][Full Text] [Related]
33. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions. Bhavna ; Ahmad FJ; Mittal G; Jain GK; Malhotra G; Khar RK; Bhatnagar A Eur J Pharm Biopharm; 2009 Feb; 71(2):282-91. PubMed ID: 18984050 [TBL] [Abstract][Full Text] [Related]
34. Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. Huang G; Diakur J; Xu Z; Wiebe LI Int J Pharm; 2008 Aug; 360(1-2):197-203. PubMed ID: 18539417 [TBL] [Abstract][Full Text] [Related]
35. Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticle optical and magnetic resonance imaging contrast agents. Meng XX; Wan JQ; Jing M; Zhao SG; Cai W; Liu EZ Acta Pharmacol Sin; 2007 Dec; 28(12):2019-26. PubMed ID: 18031618 [TBL] [Abstract][Full Text] [Related]
36. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276 [TBL] [Abstract][Full Text] [Related]
37. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system. Bjørnerud A; Johansson L NMR Biomed; 2004 Nov; 17(7):465-77. PubMed ID: 15526351 [TBL] [Abstract][Full Text] [Related]
38. MRI detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles. Yigit MV; Mazumdar D; Lu Y Bioconjug Chem; 2008 Feb; 19(2):412-7. PubMed ID: 18173225 [TBL] [Abstract][Full Text] [Related]
39. Linear assemblies of magnetic nanoparticles as MRI contrast agents. Corr SA; Byrne SJ; Tekoriute R; Meledandri CJ; Brougham DF; Lynch M; Kerskens C; O'Dwyer L; Gun'ko YK J Am Chem Soc; 2008 Apr; 130(13):4214-5. PubMed ID: 18331033 [TBL] [Abstract][Full Text] [Related]
40. Towards MRI microarrays. Hall A; Mundell VJ; Blanco-Andujar C; Bencsik M; McHale G; Newton MI; Cave GW Chem Commun (Camb); 2010 Apr; 46(14):2420-2. PubMed ID: 20379545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]